EP0109767B1 - Modified electrode - Google Patents

Modified electrode Download PDF

Info

Publication number
EP0109767B1
EP0109767B1 EP83306407A EP83306407A EP0109767B1 EP 0109767 B1 EP0109767 B1 EP 0109767B1 EP 83306407 A EP83306407 A EP 83306407A EP 83306407 A EP83306407 A EP 83306407A EP 0109767 B1 EP0109767 B1 EP 0109767B1
Authority
EP
European Patent Office
Prior art keywords
electrode
adsorption
redox
modified electrode
mediator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP83306407A
Other languages
German (de)
French (fr)
Other versions
EP0109767A1 (en
Inventor
Yasuhiro Kimura
Katsumi Niki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57196608A external-priority patent/JPS59141055A/en
Priority claimed from JP58133103A external-priority patent/JPS6024390A/en
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of EP0109767A1 publication Critical patent/EP0109767A1/en
Application granted granted Critical
Publication of EP0109767B1 publication Critical patent/EP0109767B1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/008—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions for determining co-enzymes or co-factors, e.g. NAD, ATP
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides

Definitions

  • This invention relates to a novel electrode obtained from an electrically conducting solid electrode by modification of the surface thereof, and to applications of the novel electrode.
  • An electrode which has polyvinyl pyridine, for example, immobilized on pyrolytic graphite is known (N. Oyama et al., J. Electrochem. Soc., 127, 640 (1980)). It has the disadvantage that effective use thereof is attained only in strongly acidic solutions and that the substances which can be immbolized thereon are limited to those of cationic type.
  • an electrode for use in a bioelectrocatalytic process the electrode consisting of an electrically conductive substance, e.g. pyrolytic graphite, having a chemical binding species, e.g., a bipyridyl type compound, dispersed therein.
  • an electrically conductive substance e.g. pyrolytic graphite
  • a chemical binding species e.g., a bipyridyl type compound
  • An object of this invention is to provide a novel modified electrode which overcomes the various disadvantages suffered by the prior art, which is easy to manufacture and handle, and which finds extensive utility in a variety of applications.
  • the inventors of the present invention have already made earlier inventions, including one which relates to an electrode characterized by having an aromatic group-containing strongly acidic cation exchange resin and a nitrogen-containing electron mediator immobilized on the surface of a solid conductive electrode, and to an electrochemical biosensor using the electrode.
  • This particular invention has emanated from the discovery that a modified electrode having a nitrogen-containing electron mediator stably immbilized thereon can be obtained through the medium of an aromatic group-containing strongly acidic cation exchange resin (see EP-A-0088592 published on 14.09.83).
  • a stable chemically modified electrode is easily obtained by selecting, as an electron mediator capable of responding to a biological substance without the intervention of any such aromatic group-containing strongly acidic cation exchange resin, a compound having a particular chemical structure, namely viologen dye, bipyridine, phenanthroline or 1-methoxy-5-methyl- phenazinium methyl sulphate, and by combining this mediator compound with pyrolytic graphite exposing the basal plane of graphite.
  • his modified electrode exhibits an excellent electrochemical response to biological substances such as hemoproteins, NADH, HADPH and the like.
  • a chemically modified electrode comprising an electrically conducting solid electrode of pyrolytic graphite whose basal plane is exposed, and a redox/adsorption electron mediator, characterised in that said redox/adsorption electron mediator is immbolized by adsorption onto a surface of said electrically conducting electrode, and in that said redox/adsorption electron mediator is viologen dye, bipyridine, phenanthroline or 1-methoxy-5- methyl- phenazinium methyl sulphate.
  • the adsorption site is herein used to mean “the adsorption site at which the molecule is adsorbed, i.e. is immobilized by adsorption, on the surface of an electrically conducting solid electrode”.
  • the expression “the redox site” is self-explanatory.
  • the electron mediator compounds used in this invention which are immobilized on the surface of an electrically conducting solid electrode which is pyrolytic graphite exposing the basal plane of graphite, have a particular chemical structure in which the redox site and the adsorption site are not spaced apart from one another, i.e. both sites are fused, in the molecule.
  • the mediator compounds used in this invention show both a redox function and a adsorption function, but both functions are not attributable to definitely different sites in the molecule.
  • the molecules are not only irreversibly adsorbed onto the basal plane of the graphite but also are markedly stabilized.
  • Electron mediators with such a particular chemical structure have the advantage that their over-voltage for NADH and the like is very low.
  • the (electron) mediator (compound) used in this invention having the above-explained particular chemical structure may hereinafter be referred to simply as "a redox/adsorption (electron) mediator (compound)".
  • any of the electrically conducting solid electrodes known in the art may be adopted.
  • a carbon electrode of pyrolytic graphite abundantly exposing the basal plane of graphite such as, for example, the stress- annealed pyrolytic graphite made by U.C.C. (hereinafter referred to as "SAPG) may be cited as a desirable representative.
  • the modified electrode of this invention can be easily produced by immersing a pyrolytic graphite carbon electrode exposing the basal plane of graphite as described above in an aqueous solution of the redox/adsorption electron mediator and, when necessary, subsequently washing and drying the impregnated carbon electrode.
  • the amount of the redox/adsorption electron mediator to be immobilized on the surface of the carbon electrode is preferably sufficient to form a monomolecular layer (i.e. an amount equivalent to saturated adsorption), although even when this amount is lower than the level required for saturated adsorption, the modified electrode can be effectively used.
  • the electrode of this invention is better than conventional countertypes in the following respects:
  • the modified electrode of the present invention proves to be an outstanding choice.
  • the electrode of the present invention is capable of generating an electrical current in the presence of a biological substance liable to conjugation with the aforementioned redox/adsorption electron mediator, it can be advantageously utilized as an electrode in a bioreactor.
  • the concentration of biological substance and the magnitude of the electrical current generated are in a linear relationship, the modified electrode of the present invention can be utilized as a biosensor capable of the quantitative analysis of biological substances.
  • the concentration of a specific biological substance in a given sample can be determined by fractionally separating the biological substance from the sample, for example by chromatography, by then adding the isolated biological substance to a buffer solution of pH 4 to 10, by placing the modified electrode of this invention in the resultant solution, by placing another appropriate electrode as the counter electrode in the solution, by applying an electrical potential to the opposed electrodes, and by measuring the magnitude of the electrical current consequently generated therein.
  • Examples of biological substances which respond to the redox/adsorption electron mediator include NADH, NADPH, cytochrome C 3 , cytochrome C, hemoglobin, chlorophyll, and electron-transfer systems containing these substances.
  • An SAPG electrode 5 mm in diameter was immersed for about 10 seconds in a 1 mM aqueous solution of 1-methoxy-5-methyl- phenazinium methyl sulphate and then washed and dried to produce a modified electrode.
  • NADH was electrochemically oxidized. During the oxidation, the concentration of NADH and the magnitude of the electrical current generated were measured. The results showed a linear relationship between the two quantities as indicated in Table 1.
  • An SAPG electrode 5 mm in diameter was immersed for about 10 seconds in a 1 mM aqueous solution of viologen dye and subsequently washed and dried to produce a modified electrode.
  • An SAPG electrode 5 mm in diameter was immersed for about 10 seconds in a 1 mM aqueous solution of bipyridine and washed and dried to produce a modified electrode.
  • ferrous cytochrome C was electrochemically oxidized. During the oxidation, the concentration of cytochrome C and the magnitude of the electrical current generated were measured. The results showed a . linear relationship between the two quantities as indicated in Table 3.
  • An SAPG electrode 5 mm in diameter was immersed for about 10 seconds in a 1 mM aqueous solution of methyl viologen and washed and dried to produce a modified electrode.
  • the electrode prepared as described above and a platinum electrode were set up.
  • the magnitude of electrical current generated between the electrodes was measured in the presence and absence of light (from a xenon lamp).
  • the electrical current was found to be 3 pA/cm 2 in the presence of light and zero in the absence of light. This fact implies the feasibility of photoelectric conversion.

Description

  • This invention relates to a novel electrode obtained from an electrically conducting solid electrode by modification of the surface thereof, and to applications of the novel electrode.
  • It is known that electrically conducting solid electrode surfaces can be modified by redox polymers. However, the activity of this modified electrode varies with the degree of polymerization of the redox polymer, and the electrode is active only in strong acidic solutions because electron mediators can be coupled with the polymers only in strong acidic solutions.
  • An electrode which has polyvinyl pyridine, for example, immobilized on pyrolytic graphite is known (N. Oyama et al., J. Electrochem. Soc., 127, 640 (1980)). It has the disadvantage that effective use thereof is attained only in strongly acidic solutions and that the substances which can be immbolized thereon are limited to those of cationic type.
  • It is also known from Doklady Akademii Nauk SSSR, 225, 105-108 (1975) and from "Electrochemical Studies of Biosystems", D. T. Sawyer, A.C.S. Symposium Series, 143 (1977), that electron mediators such as methyl viologen can be used in the form of a solution or a suspension with an unmodified electrode or with a chemically modified electrode. In this case, a large amount of electron mediator has to be used and, in some cases, an eJectrochemically inactive material, which may decrease the current efficiency, has to be added to the solution.
  • In DE-A-3148366, there is disclosed an electrode for use in a bioelectrocatalytic process, the electrode consisting of an electrically conductive substance, e.g. pyrolytic graphite, having a chemical binding species, e.g., a bipyridyl type compound, dispersed therein.
  • In J. Electroanal. Chem. 130, 199-207 (1981), the immobilization of phenazine methosulphate and phenazine ethosulphate on graphite electrodes is disclosed.
  • In US-A-4144143, there is disclosed the formation of a stable, apparently polymeric, film of 1,1'-dimethyl-4,4-dipyridyl dichloride on a minigrid electrode.
  • An object of this invention is to provide a novel modified electrode which overcomes the various disadvantages suffered by the prior art, which is easy to manufacture and handle, and which finds extensive utility in a variety of applications.
  • The inventors of the present invention have already made earlier inventions, including one which relates to an electrode characterized by having an aromatic group-containing strongly acidic cation exchange resin and a nitrogen-containing electron mediator immobilized on the surface of a solid conductive electrode, and to an electrochemical biosensor using the electrode. This particular invention has emanated from the discovery that a modified electrode having a nitrogen-containing electron mediator stably immbilized thereon can be obtained through the medium of an aromatic group-containing strongly acidic cation exchange resin (see EP-A-0088592 published on 14.09.83).
  • The inventors, after a further study, have found that a stable chemically modified electrode is easily obtained by selecting, as an electron mediator capable of responding to a biological substance without the intervention of any such aromatic group-containing strongly acidic cation exchange resin, a compound having a particular chemical structure, namely viologen dye, bipyridine, phenanthroline or 1-methoxy-5-methyl- phenazinium methyl sulphate, and by combining this mediator compound with pyrolytic graphite exposing the basal plane of graphite. The inventors have found that his modified electrode exhibits an excellent electrochemical response to biological substances such as hemoproteins, NADH, HADPH and the like.
  • Thus, according to the present invention, there is provided a chemically modified electrode comprising an electrically conducting solid electrode of pyrolytic graphite whose basal plane is exposed, and a redox/adsorption electron mediator, characterised in that said redox/adsorption electron mediator is immbolized by adsorption onto a surface of said electrically conducting electrode, and in that said redox/adsorption electron mediator is viologen dye, bipyridine, phenanthroline or 1-methoxy-5- methyl- phenazinium methyl sulphate.
  • Heretofore, quinones have often been used as electron mediators for NADH and the like. But prior-art compounds such as that having the formula:
    Figure imgb0001
    in which the redox site (A) and the adsorption site (B) are spaced apart from one another in the molecule, will not readily oxidize NADH because of their high overvoltage (T. Kuwana et al., J.A.C.S., 105, 1805 (1983)).
  • The expression "the adsorption site" is herein used to mean "the adsorption site at which the molecule is adsorbed, i.e. is immobilized by adsorption, on the surface of an electrically conducting solid electrode". The expression "the redox site" is self-explanatory.
  • On the contrary, the electron mediator compounds used in this invention, which are immobilized on the surface of an electrically conducting solid electrode which is pyrolytic graphite exposing the basal plane of graphite, have a particular chemical structure in which the redox site and the adsorption site are not spaced apart from one another, i.e. both sites are fused, in the molecule. Thus, the mediator compounds used in this invention show both a redox function and a adsorption function, but both functions are not attributable to definitely different sites in the molecule. Thus, the molecules are not only irreversibly adsorbed onto the basal plane of the graphite but also are markedly stabilized. Electron mediators with such a particular chemical structure have the advantage that their over-voltage for NADH and the like is very low. The (electron) mediator (compound) used in this invention having the above-explained particular chemical structure may hereinafter be referred to simply as "a redox/adsorption (electron) mediator (compound)".
  • For use in the present invention, any of the electrically conducting solid electrodes known in the art may be adopted. A carbon electrode of pyrolytic graphite abundantly exposing the basal plane of graphite such as, for example, the stress- annealed pyrolytic graphite made by U.C.C. (hereinafter referred to as "SAPG) may be cited as a desirable representative.
  • The modified electrode of this invention can be easily produced by immersing a pyrolytic graphite carbon electrode exposing the basal plane of graphite as described above in an aqueous solution of the redox/adsorption electron mediator and, when necessary, subsequently washing and drying the impregnated carbon electrode. The amount of the redox/adsorption electron mediator to be immobilized on the surface of the carbon electrode is preferably sufficient to form a monomolecular layer (i.e. an amount equivalent to saturated adsorption), although even when this amount is lower than the level required for saturated adsorption, the modified electrode can be effectively used.
  • The electrode of this invention is better than conventional countertypes in the following respects:
    • (1) The manufacture of the electrode is extremely simple because it only requires immersion of the carbon electrode in an aqueous solution of a redox/adsorption electron mediator. In addition, the consumption of the electron mediator during this immersion is notably small.
    • (2) The solution to be used for the electrode reaction is only required to possess a hydrogen ion concentration in the neighbourhood of neutrality, specifically in the pH range of 4 to 10. In other words, according to the present invention, a strongly acidic solution, which is used in making a conventional electrode and which gives rise to problems, is not required. Thus, the modified electrode of the present invention is advantageously used as an electrode capable of responding to biological substances.
    • (3) The redox/adsorption electron mediator may be effectively used in the form of a monomer and can be quantitatively immobilized. Thus, there is no need to prepare a polymer or to render uniform the degree of polymerization.
    • (4) Since the redox/adsorption electron mediator is immobilized in a monomolecular layer and retained stably in that state, the substance is consumed in a smaller amount and with greater efficiency than when it is used in the form of a solution or suspension.
    • (5) The modified electrode is practical and convenient in actual use because it is moderately hydrophilic and not susceptible to dissolution.
  • As an electrode for fulfilling its function by responding to a biological substance, therefore, the modified electrode of the present invention proves to be an outstanding choice.
  • Since the electrode of the present invention is capable of generating an electrical current in the presence of a biological substance liable to conjugation with the aforementioned redox/adsorption electron mediator, it can be advantageously utilized as an electrode in a bioreactor. In this case, since the concentration of biological substance and the magnitude of the electrical current generated are in a linear relationship, the modified electrode of the present invention can be utilized as a biosensor capable of the quantitative analysis of biological substances.
  • To be specific, the concentration of a specific biological substance in a given sample can be determined by fractionally separating the biological substance from the sample, for example by chromatography, by then adding the isolated biological substance to a buffer solution of pH 4 to 10, by placing the modified electrode of this invention in the resultant solution, by placing another appropriate electrode as the counter electrode in the solution, by applying an electrical potential to the opposed electrodes, and by measuring the magnitude of the electrical current consequently generated therein.
  • Examples of biological substances which respond to the redox/adsorption electron mediator include NADH, NADPH, cytochrome C3, cytochrome C, hemoglobin, chlorophyll, and electron-transfer systems containing these substances.
  • The present invention will now be illustrated by the following Examples.
    • Example 1
  • An SAPG electrode 5 mm in diameter was immersed for about 10 seconds in a 1 mM aqueous solution of 1-methoxy-5-methyl- phenazinium methyl sulphate and then washed and dried to produce a modified electrode.
  • With the use of this electrode, NADH was electrochemically oxidized. During the oxidation, the concentration of NADH and the magnitude of the electrical current generated were measured. The results showed a linear relationship between the two quantities as indicated in Table 1.
    Figure imgb0002
    • Example 2
  • An SAPG electrode 5 mm in diameter was immersed for about 10 seconds in a 1 mM aqueous solution of viologen dye and subsequently washed and dried to produce a modified electrode.
  • With the use of the electrode, reduced hemoglobin was electrochemically oxidized. During the oxidation, the concentration of hemoglobin and the magnitude of the electrical current generated were measured. The results showed a linear relationship between the two quantities as indicated in Table 2.
    Figure imgb0003
    • Example 3
  • An SAPG electrode 5 mm in diameter was immersed for about 10 seconds in a 1 mM aqueous solution of bipyridine and washed and dried to produce a modified electrode.
  • With the use of this electrode, ferrous cytochrome C was electrochemically oxidized. During the oxidation, the concentration of cytochrome C and the magnitude of the electrical current generated were measured. The results showed a . linear relationship between the two quantities as indicated in Table 3.
    Figure imgb0004
    • Example 4
  • When a modified electrode produced by following the procedure of Example 1 was immersed in an aqueous solution containing NADH in a concentration of 50 g/litre and an electrical potential was applied at a current density of about 10 µA/ cm2, NAD was substantially quantitatively obtained (about 90% yield).
    • Example 5
  • An SAPG electrode 5 mm in diameter was immersed for about 10 seconds in a 1 mM aqueous solution of methyl viologen and washed and dried to produce a modified electrode.
  • In 20 ml of distilled water, 3 g of polyvinyl alcohol were amply dispersed at room temperature. The resultant mixture was gradually heated under conditions enabling thorough dissolution of the solute without boiling the mixture. The solution was then gradually cooled to normal room temperature. Thereafter, bovine serum albumin was added, when necessary, to the solution in an amount of 1 % based on the weight of polyvinyl alcohol, and dissolved therein. With this solution was mixed 0.28 g of anabaena cylindrica suspension (having a chlorophyll content of about 3% by weight). The resultant mixed solution was uniformly spread in a thin layer on the aforementioned modified electrode and immediately dried in a desiccator kept in a dark room at 0 to 5°C. The dry weight was 2 mg.
  • In an aqueous phosphate buffer solution (pH 7), the electrode prepared as described above and a platinum electrode were set up. The magnitude of electrical current generated between the electrodes was measured in the presence and absence of light (from a xenon lamp). Thus, the electrical current was found to be 3 pA/cm2 in the presence of light and zero in the absence of light. This fact implies the feasibility of photoelectric conversion.

Claims (1)

  1. A chemically modified electrode comprising an electrically conducting solid electrode of pyrolytic graphite whose basal plane is exposed, and a redox/adsorption electron mediator, characterised in that said redox/asdorption electron mediator is immobilized by adsorption onto a surface of said electrically conducting electrode, and in that said redox/adsorption mediator is viologen dye, bipyridine, phenanthroline or 1-methoxy-5-methylphenazinium methyl sulphate.
EP83306407A 1982-11-09 1983-10-21 Modified electrode Expired EP0109767B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP196608/82 1982-11-09
JP57196608A JPS59141055A (en) 1982-11-09 1982-11-09 Modified electrode
JP133103/83 1983-07-21
JP58133103A JPS6024390A (en) 1983-07-21 1983-07-21 Modified electrode

Publications (2)

Publication Number Publication Date
EP0109767A1 EP0109767A1 (en) 1984-05-30
EP0109767B1 true EP0109767B1 (en) 1988-06-08

Family

ID=26467528

Family Applications (1)

Application Number Title Priority Date Filing Date
EP83306407A Expired EP0109767B1 (en) 1982-11-09 1983-10-21 Modified electrode

Country Status (3)

Country Link
US (1) US4595479A (en)
EP (1) EP0109767B1 (en)
DE (1) DE3377017D1 (en)

Families Citing this family (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6114561A (en) * 1984-06-30 1986-01-22 Terumo Corp Ph sensor
GB8500729D0 (en) * 1985-01-11 1985-02-13 Hill H A O Surface-modified electrode
GB8508053D0 (en) * 1985-03-28 1985-05-01 Genetics Int Inc Graphite electrode
GB8523631D0 (en) * 1985-09-25 1985-10-30 Pena Ltd Paul De Bioelectrochemical cell
US4704193A (en) * 1986-05-14 1987-11-03 Gte Laboratories Incorporated Covalently coupled cofactor modified electrodes and methods of synthesis and use
JPH0743339B2 (en) * 1987-07-09 1995-05-15 テルモ株式会社 Ion sensor
US4797181A (en) * 1987-08-03 1989-01-10 Gte Laboratories Incorporated Flavin cofactor modified electrodes and methods of synthesis and use
FR2630546B1 (en) * 1988-04-20 1993-07-30 Centre Nat Rech Scient ENZYMATIC ELECTRODE AND ITS PREPARATION METHOD
US5776672A (en) * 1990-09-28 1998-07-07 Kabushiki Kaisha Toshiba Gene detection method
JP3394262B2 (en) 1997-02-06 2003-04-07 セラセンス、インク． Small volume in vitro analyte sensor
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6251260B1 (en) 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
EP2322645A1 (en) 1999-06-18 2011-05-18 Abbott Diabetes Care Inc. Mass transport limited in vivo analyte sensor
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
WO2002078512A2 (en) 2001-04-02 2002-10-10 Therasense, Inc. Blood glucose tracking apparatus and methods
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
DE60238119D1 (en) 2001-06-12 2010-12-09 Pelikan Technologies Inc ELECTRIC ACTUATOR ELEMENT FOR A LANZETTE
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
EP1404232B1 (en) 2001-06-12 2009-12-02 Pelikan Technologies Inc. Blood sampling apparatus and method
ES2357485T3 (en) 2001-06-12 2011-04-26 Pelikan Technologies Inc. INTEGRATED BLOOD SAMPLE ANALYSIS SYSTEM WITH MULTIPLE USES SAMPLE TAKING MODULE.
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7699791B2 (en) 2001-06-12 2010-04-20 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US7344894B2 (en) 2001-10-16 2008-03-18 Agilent Technologies, Inc. Thermal regulation of fluidic samples within a diagnostic cartridge
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7582099B2 (en) 2002-04-19 2009-09-01 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7485128B2 (en) 2002-04-19 2009-02-03 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7244265B2 (en) 2002-04-19 2007-07-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7374544B2 (en) 2002-04-19 2008-05-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7713214B2 (en) 2002-04-19 2010-05-11 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7563232B2 (en) 2002-04-19 2009-07-21 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7524293B2 (en) 2002-04-19 2009-04-28 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7410468B2 (en) 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7141058B2 (en) 2002-04-19 2006-11-28 Pelikan Technologies, Inc. Method and apparatus for a body fluid sampling device using illumination
WO2003088824A2 (en) 2002-04-19 2003-10-30 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
GB0214993D0 (en) * 2002-06-28 2002-08-07 Marconi Applied Techn Ltd Electrochemical sensing
US20060008863A1 (en) * 2002-06-28 2006-01-12 E2V Technologies (Ul) Limited Electrochemical sensing using an enzyme electrode
WO2004042138A1 (en) * 2002-11-06 2004-05-21 Tex-A-Tec Ag Method for the electrochemical reduction of vat and sulphur dyes
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US8262614B2 (en) 2003-05-30 2012-09-11 Pelikan Technologies, Inc. Method and apparatus for fluid injection
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
EP1635700B1 (en) 2003-06-13 2016-03-09 Sanofi-Aventis Deutschland GmbH Apparatus for a point of care device
WO2005033659A2 (en) 2003-09-29 2005-04-14 Pelikan Technologies, Inc. Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US8668656B2 (en) 2003-12-31 2014-03-11 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
WO2005085825A1 (en) * 2004-03-04 2005-09-15 Isis Innovation Ltd Electrochemical sensors
WO2006011062A2 (en) 2004-05-20 2006-02-02 Albatros Technologies Gmbh & Co. Kg Printable hydrogel for biosensors
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US20080071158A1 (en) 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US7440121B2 (en) * 2006-09-20 2008-10-21 Lawrence Livermore National Security, Llc Optically measuring interior cavities
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
EP2265324B1 (en) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US20100213057A1 (en) 2009-02-26 2010-08-26 Benjamin Feldman Self-Powered Analyte Sensor
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
EP2473099A4 (en) 2009-08-31 2015-01-14 Abbott Diabetes Care Inc Analyte monitoring system and methods for managing power and noise
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
WO2013070794A2 (en) 2011-11-07 2013-05-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3148366A1 (en) * 1980-12-10 1982-09-23 National Research Development Corp., London BIOELECTROCATALYTIC METHOD AND BIOELECTROCATALYTIC ELECTRODE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144143A (en) * 1977-10-25 1979-03-13 Virginia Commonwealth University Electrolytic production of stable methyl viologen film
DE3264957D1 (en) * 1981-01-14 1985-09-05 Terumo Corp Ion sensor
JPS58120222A (en) * 1982-01-12 1983-07-18 Seiko Instr & Electronics Ltd Functional electrode
JPS58153154A (en) * 1982-03-09 1983-09-12 Ajinomoto Co Inc Qualified electrode
US4414080A (en) * 1982-05-10 1983-11-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Photoelectrochemical electrodes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3148366A1 (en) * 1980-12-10 1982-09-23 National Research Development Corp., London BIOELECTROCATALYTIC METHOD AND BIOELECTROCATALYTIC ELECTRODE

Also Published As

Publication number Publication date
DE3377017D1 (en) 1988-07-14
US4595479A (en) 1986-06-17
EP0109767A1 (en) 1984-05-30

Similar Documents

Publication Publication Date Title
EP0109767B1 (en) Modified electrode
US4321123A (en) Coenzyme immobilized electrode
Raoof et al. Electrocatalytic oxidation of glutathione at carbon paste electrode modified with 2, 7-bis (ferrocenyl ethyl) fluoren-9-one: application as a voltammetric sensor
Kalcher et al. Sensors based on carbon paste in electrochemical analysis: a review with particular emphasis on the period 1990–1993
Navrátilová et al. Clay modified electrodes: present applications and prospects
Cassidy et al. Electrochemistry at very high potentials: The use of ultramicroelectrodes in the anodic oxidation of short-chain alkanes
EP0184909A2 (en) Bioelectrochemical assay and apparatus
Lange et al. Amperometric determination of glucose with a ferrocene-mediated glucose oxidase/polyacrylamide gel electrode
US5264092A (en) Redox polymer modified electrode for the electrochemical regeneration of coenzyme
FI88515B (en) Enzyme electrode
Raoof et al. Electrocatalytic oxidation and highly selective voltammetric determination of L-cysteine at the surface of a 1-[4-(ferrocenyl ethynyl) phenyl]-1-ethanone modified carbon paste electrode
Vidal et al. A chronoamperometric sensor for hydrogen peroxide based on electron transfer between immobilized horseradish peroxidase on a glassy carbon electrode and a diffusing ferrocene mediator
JP2003098142A (en) Method for monitoring bioelectrochemical reaction and its reaction medium
EP0088592A2 (en) Chemically modified electrodes and their uses
JPS5816698B2 (en) Enzyme electrode and its manufacturing method
Nakabayashi et al. Amperometric glucose sensors fabricated by electrochemical polymerization of phenols on carbon paste electrodes containing ferrocene as an electron transfer mediator
Wang et al. Ion-exchange voltammetry at poly (ester-sulfonic acid) film coated electrodes for trace analysis
Zheng et al. Electrocatalytic reduction of dioxygen on hemin based carbon paste electrode
Bartlett et al. Approaches to the Integration of Electrochemistry and Biotechnology: I. Enzyme‐Modified Reticulated Vitreous Carbon Electrodes
Hajizadeh et al. chemical cross-linking of a redox mediator thionin for electrocatalytic oxidation of reduced β-nicotinamide adenine dinucleotide
Sun Immobilization of horseradish peroxidase on a self-assembled monolayer modified gold electrode for the detection of hydrogen peroxide
Moghaddam et al. A novel electrochemiluminescnece sensor based on an Ru (bpy) 32+-Eu2O3-Nafion nanocomposite and its application in the detection of diphenhydramine
Lukachova et al. Non-aqueous enzymology approach for improvement of reagentless mediator-based glucose biosensor
Canbay et al. Ionic liquid modified carbon paste electrode and investigation of its electrocatalytic activity to hydrogen peroxide
Gligor et al. Electrochemical behavior of carbon paste electrodes modified with methylene green immobilized on two different X type zeolites

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): DE FR GB

17P Request for examination filed

Effective date: 19841109

17Q First examination report despatched

Effective date: 19860319

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB

REF Corresponds to:

Ref document number: 3377017

Country of ref document: DE

Date of ref document: 19880714

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19920918

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19920923

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19921231

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19931021

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19931021

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Effective date: 19940630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19940701

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST